Abstract

Amiodarone is commonly used to instantly reverse potentially fatal myocardial arrhythmias, but may also potentiate arrhythmic adverse effects, such as QT prolongation and torsades de pointes. This case describes a 56-year-old male patient who, after experiencing a myocardial infarction, had undergone temporary pacemaker (TPM) insertion for bradycardia-induced ventricular tachycardia (VT); however, his VT persisted post-insertion and intravenous amiodarone was administered. Within a few minutes, monomorphic VT occurred, which progressed to polymorphic VT arrest (i.e. torsades de pointes). The polymorphic VT induced by amiodarone resolved on withdrawal of amiodarone and a subsequent switch to lignocaine. In view of suspected TPM dislodgement, a new TPM was inserted and paced at a higher rate. The patient did not show further ventricular arrhythmia and, prior to discharge, had a permanent pacemaker implanted and was hemodynamically stable.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call